Guangzhou Springsnow Biotech

Guangzhou Springsnow Biotechnology Co., Ltd. (广州春雪生物科技有限公司) was set up in 2024 as a joint venture between Shandong Springsnow Food Co., Ltd., a listed poultry processor, and Lihe (Guangzhou). It works from the science and technology innovation base at 80 Langri Road in Science City, Huangpu District, Guangzhou.

The company makes bioactive peptides and extracts from animal raw material, drawing on its parent's poultry processing for feedstock. Its listed products are chicken imidazole dipeptide, sold as a chicken concentrate powder and containing carnosine and anserine, peptide from the gizzard lining known in Chinese medicine as Galli gigeriae endothelium corneum, cartilage extract and keratin peptide.

Output goes to functional food, supplement and biomedical intermediate manufacturers rather than to consumers, and the company takes contract formulation work. Its stated export markets are Eastern Europe and other parts of Asia.